Myriad Genetics |
Dátum/Idő | / |
Vált. / Vált.(%) | - / |
Vétel | - |
Eladás | - |
Nyitó | - |
Előző záró | - |
Napi max | - |
Napi min | - |
Forgalom (db) [USD] | - |
Forgalom (db) [Egységek] | |
Árrögzítés | |
ISIN | US62855J1043 |
Szimbólum | MYGN |
Tőzsde | IEX |
Típus | Részvény |
Egyéb tőzsdék
Tőzsde | Utolsó ár | Forgalom (db) | |
---|---|---|---|
NASDAQ | 21,6050 | ![]() |
210.677 |
IEX | 21,63 | ![]() |
14.757 |
Cboe US | 21,70 | ![]() |
11.218 |
TradeGate | 20,860 | ![]() |
10 |
Xetra | 20,580 | ![]() |
0 |
Hannover | 20,790 | ![]() |
0 |
Frankfurt | 20,8300 | ![]() |
0 |
Berlin | 20,810 | ![]() |
0 |
München | 20,790 | ![]() |
0 |
Hamburg | 20,790 | ![]() |
0 |
Düsseldorf | 20,250 | ![]() |
0 |
Lang & Schwa.. | 20,190 | ![]() |
|
Stuttgart | 20,260 | ![]() |
|
gettex | 20,240 | ![]() |
|
Quotrix | 20,9300 | ![]() |
|
London Domes.. | 22,06 | 100 |
Hírek
- Myriad Genetics Advances Precision Oncology with New Precise™ Solutions, Combines Genetic Insights from Multiple Tests to Guide Treatment Decisions and Improve Patient Care
14.03.2022 / 12:05 - GlobeNewswire - Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer
12.03.2022 / 01:05 - GlobeNewswire - Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies
08.03.2022 / 13:22 - GlobeNewswire - Myriad Genetics CEO Paul Diaz to Speak at 42nd Annual Cowen Health Care Conference
02.03.2022 / 22:30 - GlobeNewswire - Myriad Genetics Reports Fourth Quarter 2021 Results, Provides Updates on Product Performance and Growth Initiatives
24.02.2022 / 15:00 - GlobeNewswire
Kattintson az
-ra, hogy aktiválhassa a push árfolyamokat!
